How next-generation antibody engineering is changing medicine | SynBioBeta Spotlight

How is next-generation antibody engineering changing medicine? Biopharma is in the midst of a renaissance, and at SynBioBeta 2019, Twist Biopharma CSO Aaron Sato took to the stage to share how the ability to write huge amounts of DNA is enabling new, previously impossible treatments.
SynBioBeta is the premier innovation network for biological engineers, investors, innovators, and entrepreneurs who share a passion for using biology to build a better, more sustainable universe. We provide our community members with personal and professional development support, as well as valuable opportunities for partnership, collaboration, networking, and education.
To learn more about SynBioBeta visit:
www.synbiobeta...
For further information about our sponsor Twist visit:
www.twistbioph...

[@lotusonpole5209]

This technology is simply amazing. For years medicine has advanced it's imaging cababilities at an amazing rate while the surgical procedures and medicines have lagged behind. Finally we seem to be at the dawn of some real advances in medicine. Besides the cures to disease, it sounds like they will surely advance detection capabilities as well. Surely DNA never lies. Job Well Done to all the companies, scientists and engineers working on this! Cheers!